Cue Biopharma, Inc.
CUENASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $118.32M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.23$45.50
- Volume (live)
- -
- Avg. volume (3M)
- 363.68K
Cue Biopharma (CUE) Stock Price & Financial Analysis
Cue Biopharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $18.04 - $19.35 |
|---|---|
| 52-Week High | $45.50 |
| 52-Week Low | $0.23 |
| Open | $18.88 |
| Volume (last close) | 79.37K |
| Average Volume (3M) | 363.68K |
| Revenue (TTM) | 37.65M |
|---|---|
| Net Income (TTM) | -164.11M |
| Free Cash Flow (TTM) | -50.17M |
| EPS (TTM) | −$36.08 |
| Profit Margin | -435.83% |
| Operating Margin | -261.97% |
| Return on Equity (ROE) | -7104.24% |
| Debt to Equity | 1.33 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 118.32M |
|---|---|
| Shares Outstanding | 6.34M |
| Price to Sales (P/S) | 3.14 |
| Price to Book (P/B) | 51.22 |
| EV/EBITDA | -0.66 |
| 50-Day MA | $26.95 |
|---|---|
| 200-Day MA | $20.09 |
| 1-Year Change | +2320.86% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Cue Biopharma at a Glance
As of the Oct 23, 2026 close, Cue Biopharma (CUE) has a market capitalization of $118.32M. The stock trades at 3.1× sales. Over the trailing twelve months it lost $164.11M on revenue of $37.65M and burned $50.17M of free cash flow. Revenue grew 476.9% year over year.
As of its latest reported balance sheet, it holds $17.39M in cash and securities against $3.08M of debt, a net cash position of $14.31M.
Cue Biopharma does not currently pay a dividend.
The share price is up 2320.9% over the past year. At $18.66 (the Oct 23, 2026 close) it sits within its 52-week range of $0.23 to $45.50, below its 200-day moving average of $20.09.
Frequently Asked Questions About Cue Biopharma
What is the current stock price for CUE?
As of the Oct 23, 2026 close, CUE stock trades at $18.66. The 52-week range is $0.23–$45.50, with a day range of $18.04–$19.35.
What is the P/E ratio for CUE?
The P/E ratio (Price-to-Earnings) for CUE is shown in the Key Statistics section. This valuation metric helps compare Cue Biopharma, Inc. to industry peers.
Does CUE pay dividends?
Cue Biopharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CUE?
Analyst ratings and recommendations for CUE are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CUE?
As of the Oct 23, 2026 close, Cue Biopharma's market capitalization is $118.3M, classifying it as a micro-cap company. Cue Biopharma operates in the Healthcare sector within the Biotechnology industry.